Napp Pharmaceuticals Limited

Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0GW
Telephone: +44 (0)1223 424 444
Fax: +44 (0)1223 424 441
WWW: http://www.napp.co.uk
Medical Information Fax: +44 (0)1223 424 912

Patient Information Leaflet last updated on the eMC: 02/07/2010
PIL Remedeine and Remedeine forte tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/07/2010 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 25/09/2009 and displayed until 02/07/2010
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 22/08/2008 and displayed until 25/09/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
  • Change to date of revision
Updated on 02/03/2007 and displayed until 22/08/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to dosage and administration
  • Change to date of revision
  • Change to side-effects
Updated on 22/09/2004 and displayed until 02/03/2007
Reasons for adding or updating:
  • Change to packaging
  • Change to date of revision
Updated on 01/11/2000 and displayed until 22/09/2004
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   paracetamol
   dihydrocodeine tartrate